Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid

SIMPLE SUMMARY: The first core tip of this study is that we summarized the experience of conversion therapy of intrahepatic cholangiocarcinoma (IHCC) in a single center and found conversion therapy could provide a significant improvement in the overall survival of patients with IHCC. Previous studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiwei, Jin, Yun, Guo, Yinghao, Tan, Zhenhua, Zhang, Xiaoxiao, Ye, Dan, Yu, Yuanquan, Peng, Shuyou, Zheng, Lei, Li, Jiangtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967139/
https://www.ncbi.nlm.nih.gov/pubmed/33803322
http://dx.doi.org/10.3390/cancers13051179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967139/
https://www.ncbi.nlm.nih.gov/pubmed/33803322
http://dx.doi.org/10.3390/cancers13051179

Ejemplares similares